What Is Cognitive Rehabilitation for nrSPMS? Nonrelapsing secondary progressive multiple sclerosis (nrSPMS) comes with many challenges. One of the biggest can be its impact on your cognition, which ...
Medthera's WalkPort is designed to help people with mobility and gait issues, including those with MS, safely stand and ...
Hosted on MSN
Breakthrough multiple sclerosis therapy by UCSF doctor transforms treatment for millions
Dr. Stephen Hauser was a young resident at Harvard when he met his first patient with multiple sclerosis, a woman with a thriving professional life who’d been completely wiped out by her condition, ...
There is no increased relapse risk in patients with multiple sclerosis (MS) and comorbid cancer who are receiving immune checkpoint inhibitor (ICI) therapy, results of a small study suggest. MS ...
A committee in the EU recommended that tolebrutinib, to be sold as Cenrifki, be approved for people with SPMS with no relapses for two years.
Multiple sclerosis (MS) is a debilitating autoimmune disease of the brain and spinal cord. The disease can affect everyone differently, but depending on the progression and severity of the disease, ...
Combo MS therapy fails to cut relapse risk Combining interferon beta-1a and glatiramer acetate therapy does not provide added clinical benefit to patients with multiple sclerosis. HealthDay News — A ...
A stem cell treatment commonly used for blood cancer appears effective in treating one form of MS The treatment has been available since the 1990s but questions about safety and difficulty have ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results